Structure Therapeutics, Inc. (GPCR)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Structure Therapeutics, Inc. (GPCR)
Company Performance

Current Price

as of Oct 16, 2024

$38.99

P/E Ratio

N/A

Market Cap

$2.23B

Description

Structure Therapeutics, Inc. is a clinical stage global biopharmaceutical company, which engages in developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. The company was founded by Raymond Stevens in February 2019 and is headquartered in South San Francisco, CA.

Metrics

Overview

  • HQSouth San Francisco, CA
  • SectorHealth Technology
  • IndustryBiotechnology
  • TickerGPCR
  • Price$38.99+7.41%

Trading Information

  • Market Cap$2.23B
  • Float95.78%
  • Average Daily Volume (1m)796,743
  • Average Daily Volume (3m)692,375
  • EPS-$2.24

Company

  • RevenueN/A
  • Rev Growth (1yr)N/A
  • Net Income-$26.00M
  • Gross MarginN/A
  • EBITDA MarginN/A
  • EBITDA-$33.05M
  • EV$1.02B
  • EV/RevenueN/A
  • P/EN/A
  • P/SN/A
  • P/B2.42
Documents